These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 8143649)

  • 1. Hazard identification: efficiency of short-term tests in identifying germ cell mutagens and putative nongenotoxic carcinogens.
    Waters MD; Stack HF; Jackson MA; Bridges BA
    Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):61-72. PubMed ID: 8143649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
    Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
    Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic toxicology of putative nongenotoxic carcinogens.
    Jackson MA; Stack HF; Waters MD
    Mutat Res; 1993 Mar; 296(3):241-77. PubMed ID: 7680106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic toxicology data in the evaluation of potential human environmental carcinogens.
    Waters MD; Stack HF; Jackson MA
    Mutat Res; 1999 Jul; 437(1):21-49. PubMed ID: 10425388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutagenesis; 1986 Jan; 1(1):3-16. PubMed ID: 3325732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
    Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
    Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The parallelogram approach in studies of genotoxic effects.
    Anderson D; Sorsa M; Waters MD
    Mutat Res; 1994; 313(2-3):101-15. PubMed ID: 7523897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical effective methods to detect genotoxic carcinogens and neoplasm-promoting agents.
    Weisburger JH; Williams GM
    Environ Health Perspect; 1991 Jan; 90():121-6. PubMed ID: 2050049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and impact of the Gene-Tox-Program, genetic activity profiles, and their computerized data bases.
    Waters MD
    Environ Mol Mutagen; 1994; 23 Suppl 24():67-72. PubMed ID: 8162911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Tg rasH2 mouse in cancer hazard identification.
    Morton D; Alden CL; Roth AJ; Usui T
    Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An approach to identifying specialized batteries of bioassays for specific classes of chemicals: class analysis using mutagenicity and carcinogenicity relationships and phylogenetic concordance and discordance patterns. 1. Composition and analysis of the overall data base. A report of phase II of the U.S. Environmental Protection Agency Gene-Tox Program.
    Ray VA; Kier LD; Kannan KL; Haas RT; Auletta AE; Wassom JS; Nesnow S; Waters MD
    Mutat Res; 1987 May; 185(3):197-241. PubMed ID: 3574331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic toxicity of human carcinogens and its implications.
    Shelby MD
    Mutat Res; 1988 Jan; 204(1):3-15. PubMed ID: 3277048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxic agents detected by plant bioassays.
    Ma TH; Cabrera GL; Owens E
    Rev Environ Health; 2005; 20(1):1-13. PubMed ID: 15835495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph Series.
    Bartsch H; Malaveille C
    Cell Biol Toxicol; 1989 Jun; 5(2):115-27. PubMed ID: 2766027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
    Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
    Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between carcinogenicity and mutagenicity based on chemicals evaluated in the IARC monographs.
    Bartsch H; Tomatis L
    Environ Health Perspect; 1983 Jan; 47():305-17. PubMed ID: 6337827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.